Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nuclear Factor Kappa B Subunit 1 (NFκB1) is a key member of the NF-κB family of transcription factors. It is encoded by the NFKB1 gene and produces both a 105 kDa precursor protein (p105) and a 50 kDa processed form (p50). NFκB complexes regulate the transcription of over 200 genes involved in immune response, inflammation, cell survival, apoptosis, development, and stress responses. The most common active complex is the p65-p50 heterodimer. Activation occurs through the canonical or non-canonical pathways, ultimately leading to the translocation of NFκB dimers to the nucleus and binding to DNA. Dysregulation is associated with a wide range of diseases, including cancer, autoimmune disorders, and inflammatory conditions.
NFκB inhibitors prevent the translocation of NFκB dimers to the nucleus and/or their binding to DNA, thus inhibiting the expression of target genes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear Factor Kappa B Subunit 1 (NF-κB1).